Intrinsic Value of S&P & Nasdaq Contact Us

scPharmaceuticals Inc. SCPH NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.00
+129.3%

scPharmaceuticals Inc. (SCPH) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 5 Buy, 3 Hold.

The consensus price target is $13.00, representing an upside of 129.3% from the current price $5.67.

SCPH Stock — 12-Month Price Forecast

$13.00
▲ +129.28% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for scPharmaceuticals Inc., the price target is $13.00.
The average price target represents a +129.28% change from the last price of $5.67.

SCPH Analyst Ratings

Buy
8
Ratings
5 Buy
3 Hold
Based on 8 analysts giving stock ratings to scPharmaceuticals Inc. in the past 3 months
Rating breakdown
Buy
5 63%
Hold
3 38%
63%
Buy
5 analysts
38%
Hold
3 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message